← Back to Clinical Trials
Recruiting NCT06456242

Contingency Management to Promote Smoking Cessation

Trial Parameters

Condition Smoking Cessation
Sponsor University of Kansas Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-20
Completion 2025-12-30
Interventions
CounsCM+MedCM (Health Rewards)

Brief Summary

Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.

Eligibility Criteria

Inclusion Criteria: * Smoked in the past 30 days * Smoke at least 1 cigarette per day when they smoke * ≥ 18 years old * Kansas resident * Speak/read English * Access to a mobile phone * Mobile phone receives text messages * No varenicline contraindications (no acute renal impairment) * Insurance coverage for varenicline * Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status) * Cognitively able to participate * Physically able to participate * Not pregnant/breastfeeding Exclusion Criteria: * Medically ineligible for varenicline * Patient on smoking cessation medication within 2 weeks of admission date * Patient already talked to quitline in the past 2 weeks. * Patients participating in other quit smoking program or research study

Related Trials